These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24740545)

  • 1. Cushing's syndrome in type 2 diabetes patients with poor glycemic control.
    Gungunes A; Sahin M; Demirci T; Ucan B; Cakir E; Arslan MS; Unsal IO; Karbek B; Calıskan M; Ozbek M; Cakal E; Delibasi T
    Endocrine; 2014 Dec; 47(3):895-900. PubMed ID: 24740545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.
    Terzolo M; Reimondo G; Chiodini I; Castello R; Giordano R; Ciccarelli E; Limone P; Crivellaro C; Martinelli I; Montini M; Disoteo O; Ambrosi B; Lanzi R; Arosio M; Senni S; Balestrieri A; Solaroli E; Madeo B; De Giovanni R; Strollo F; Battista R; Scorsone A; Giagulli VA; Collura D; Scillitani A; Cozzi R; Faustini-Fustini M; Pia A; Rinaldi R; Allasino B; Peraga G; Tassone F; Garofalo P; Papini E; Borretta G
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3467-75. PubMed ID: 22767639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycemic control on the overnight dexamethasone suppression test in patients with diabetes mellitus.
    Kaye TB; Rubin RA; Goldfine AB; Rajamani K; Kinsley BT; Vischer UM; Simonson DC
    J Clin Endocrinol Metab; 1992 Mar; 74(3):640-4. PubMed ID: 1740499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome?
    Cansu GB; Atılgan S; Balcı MK; Sarı R; Özdem S; Altunbaş HA
    Hormones (Athens); 2017 Jan; 16(1):22-32. PubMed ID: 28500825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.
    Mojtahedzadeh M; Shaesteh N; Haykani M; Tran JLA; Mangubat M; Shahinian HK; Nachnani R; Zopey M; Saidian J; Thomas A; Lee ML; McCutcheon IE; Friedman TC
    Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients.
    Leibowitz G; Tsur A; Chayen SD; Salameh M; Raz I; Cerasi E; Gross DJ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):717-22. PubMed ID: 8759185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult Cushing's syndrome in type-2 diabetes.
    Catargi B; Rigalleau V; Poussin A; Ronci-Chaix N; Bex V; Vergnot V; Gin H; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5808-13. PubMed ID: 14671173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushing's disease.
    Murakami H; Nigawara T; Sakihara S; Kageyama K; Yamashita M; Matsuki K; Tanabe J; Matsui J; Tamasawa N; Suda T
    Endocr J; 2010; 57(3):267-72. PubMed ID: 20086312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis.
    Felšöci M; Schroner Z; Petrovičová J; Lazúrová I
    Wien Klin Wochenschr; 2011 Jan; 123(1-2):28-33. PubMed ID: 21165705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased diagnostic probability of subclinical Cushing's syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus.
    Caetano MS; Silva Rdo C; Kater CE
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1118-27. PubMed ID: 18157388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
    Montwill J; Igoe D; McKenna TJ
    Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical Cushing's syndrome.
    Reincke M
    Endocrinol Metab Clin North Am; 2000 Mar; 29(1):43-56. PubMed ID: 10732263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
    Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients].
    Contreras LN; Cardoso E; Lozano MP; Pozzo J; Pagano P; Claus-Hermbeg H
    Medicina (B Aires); 2000; 60(3):326-30. PubMed ID: 11050809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
    Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.